Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth B Gordon

Showing results (11-20 of 136) with videos related to

Pageof 14
Sort By:
JAMA Dermatology|February 6, 2020
Comparative Effectiveness Studies for Psoriasis-The Methods MatterBruce Strober, Kenneth B Gordon
Journal of Drugs in Dermatology : JDD|January 9, 2004
Remittive effects of intramuscular alefacept in psoriasisKenneth B Gordon, Richard G Langley
Skinmed|December 16, 2003
Evolution of biologic therapies for the treatment of psoriasisKenneth B Gordon, Thomas S McCormick
Seminars in Cutaneous Medicine and Surgery|July 1, 2014
New and emerging therapies in psoriasisCraig L Leonardi, Kenneth B Gordon
JAMA Dermatology|June 7, 2018
Core Outcome Sets for Psoriasis Clinical Trials: Definition, Consensus, and AcceptanceBruce E Strober, Kenneth B Gordon
Seminars in Cutaneous Medicine and Surgery|July 1, 2014
Understanding therapeutic pathways and comorbidities in psoriasisKenneth B Gordon, Bruce E Strober
Rheumatic Diseases Clinics of North America|July 18, 2025
Combined Dermatology/Rheumatology Clinics for Management of Psoriatic Disease: Current StateEric M Ruderman, Kenneth B Gordon
Journal of the American Academy of Dermatology|August 2, 2003
The immunology of psoriasis and biologic immunotherapyStephanie L Mehlis, Kenneth B Gordon
Journal of the American Academy of Dermatology|February 21, 2006
The treatment of psoriasis and psoriatic arthritis: an interdisciplinary approachKenneth B Gordon, Eric M Ruderman
Journal of Drugs in Dermatology : JDD|January 15, 2008
Duration of remission of biologic agents for chronic plaque psoriasisRichard G Langley, Kenneth B Gordon
Pageof 14

Showing results (11-20 of 136) with videos related to

Sort By:
Pageof 14
JAMA Dermatology|February 6, 2020
Comparative Effectiveness Studies for Psoriasis-The Methods MatterBruce Strober, Kenneth B Gordon
Journal of Drugs in Dermatology : JDD|January 9, 2004
Remittive effects of intramuscular alefacept in psoriasisKenneth B Gordon, Richard G Langley
Skinmed|December 16, 2003
Evolution of biologic therapies for the treatment of psoriasisKenneth B Gordon, Thomas S McCormick
Seminars in Cutaneous Medicine and Surgery|July 1, 2014
New and emerging therapies in psoriasisCraig L Leonardi, Kenneth B Gordon
JAMA Dermatology|June 7, 2018
Core Outcome Sets for Psoriasis Clinical Trials: Definition, Consensus, and AcceptanceBruce E Strober, Kenneth B Gordon
Seminars in Cutaneous Medicine and Surgery|July 1, 2014
Understanding therapeutic pathways and comorbidities in psoriasisKenneth B Gordon, Bruce E Strober
Rheumatic Diseases Clinics of North America|July 18, 2025
Combined Dermatology/Rheumatology Clinics for Management of Psoriatic Disease: Current StateEric M Ruderman, Kenneth B Gordon
Journal of the American Academy of Dermatology|August 2, 2003
The immunology of psoriasis and biologic immunotherapyStephanie L Mehlis, Kenneth B Gordon
Journal of the American Academy of Dermatology|February 21, 2006
The treatment of psoriasis and psoriatic arthritis: an interdisciplinary approachKenneth B Gordon, Eric M Ruderman
Journal of Drugs in Dermatology : JDD|January 15, 2008
Duration of remission of biologic agents for chronic plaque psoriasisRichard G Langley, Kenneth B Gordon
Pageof 14